| Nov 1 |
Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
|
| Oct 31 |
BioNTech to Host Innovation Series R&D Day on November 14, 2024
|
| Oct 29 |
Pfizer CEO: The activist investors are 'too late'
|
| Oct 25 |
BioNTech to Report Q3 Earnings: Is a Beat in the Cards?
|
| Oct 23 |
A slow start for self-amplifying mRNA vaccines
|
| Oct 21 |
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
|
| Oct 21 |
BioNTech's Oncology Gamble: High Stakes, Big Potential
|
| Oct 21 |
FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy
|
| Oct 21 |
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
|
| Oct 18 |
mRNA licensing agreements surge 800% amid GSK lawsuits
|
